| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
2 companies
Westlake Biopartners Fund I, L.P. is 10% Owner at LTGO, with reported holdings spanning 2 companies.
Westlake Biopartners Fund I, L.P.'s largest disclosed position is in LTGO as 10% Owner, worth about $30.5M.
Westlake Biopartners Fund I, L.P. has 2 Form 4 filings on record from February 2024 to August 2026, across 2 companies: 10% Owner at Latigo Biotherapeutics (LTGO), 2026; 10% Owner at Kyverna Therapeutics (KYTX), 2024.
The 9 reported transactions were 9 conversions.
There are no priced open-market purchases or sales on record, so none of these filings shows a decision to buy or sell shares in the market.
No transactions found
Try adjusting your filters or search criteria